Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
TMPRSS2
Name:
transmembrane serine protease 2
Location:
21q22.3
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT01496157 | Evaluation of Prostate-specific Membrane Antigen PSMA-Based PET Imaging of Primary Prostate Cancer | View | |
| NCT01350180 | Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis | View | |
| NCT01858441 | Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate | View | |
| NCT02288936 | Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer | View | |
| NCT02573636 | The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation Therapy | View | |
| NCT01020448 | Effect of Triptorelin Decapeptyl 225 mg on Two Biomarkers in Patients With Advanced Prostate Cancer | View | |
| NCT04196803 | Ancillary Study of Methylation Biomarkers in a Randomized Controlled Trial of a Personalized Prevention of Colorectal Cancer | View | |
| NCT04353180 | Assessment the Activity Value of Isotretinoin 13- Cis-Retinoic Acid in the Treatment of COVID-19 Isotretinoin in Treatment of COVID-19 Randomized | View | |
| NCT04457609 | Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients | View | |
| NCT04578236 | Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease Serine 2 TMPRSS2 | View | |
| NCT04577378 | Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 An Innovative Therapeutic Approach COVID-19 | View | |
| NCT04623385 | Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword | View | |
| NCT04658433 | The Effect of Omega -3 Supplements on the Serum Levels of ACEACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19 A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People | View | |
| NCT04729491 | EAT-DUTA AndroCoV Trial | View | |
| NCT05797597 | Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease | View | |
| NCT04425317 | Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients | View | |
| NCT04321096 | The Impact of Camostat Mesilate on COVID-19 Infection | View | |
| NCT04385836 | Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2 | View | |
| NCT04411563 | Epigenetic Tools as Prognostic Predictors in Covid19 | View | |
| NCT04608266 | CAMOVID Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients | View | |
| NCT02588404 | The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient | View | |
| NCT04465474 | Coronavirus Disease 2019 COVID-19 During Pregnancy Prevalence of Seroconversion Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission COVID-MAP | View | |
| NCT04470544 | Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 | View | |
| NCT04352400 | Efficacy of Nafamostat in Covid-19 Patients RACONA Study | View | |
| NCT04355026 | Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia | View | |
| NCT04509999 | Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection | View | |
| NCT04640610 | Angiotensin-converting Enzyme 2 ACE2 Expression in Tonsils and Adenoids | View | |
| NCT04681430 | Reconvalescent PlasmaCamostat Mesylate Early in SARS-CoV-2 Q-PCR COVID-19 Positive High-risk Individuals | View | |
| NCT04475601 | Enzalutamide Treatment in COVID-19 | View | |
| NCT04480593 | The Use of Brazilian Green Propolis Extract EPP-AF in Patients Affected by COVID-19 | View | |
| NCT04652765 | Camostat With Bicalutamide for COVID-19 | View | |
| NCT05126628 | The South Proxa-Rescue AndroCoV Trial Against COVID-19 | View | |
| NCT05157217 | Impact of the Genetic Polymorphism on COVID-19 in Egypt | View |